KM02894
KM02894 is an inhibitor of glutamate release. Cancer cells release high levels of glutamate, which disrupts normal bone turnover and may lead to cancer-induced bone pain. KM02894 can be used for cancer related research[1].
Product Specifications
CAS Number
[116850-74-9]
UNSPSC
12352005
Hazard Statement
H301
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/km02894.html
Purity
99.31
Solubility
DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C) |DMSO : 33.33 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
CNC(NNC(C1=CC=CS1)=O)=S
Molecular Formula
C7H9N3OS2
Molecular Weight
215.30
Precautions
P264-P270-P330-P405-P501
References & Citations
[1]Fazzari J, et.al. Inhibitors of glutamate release from breast cancer cells; new targets for cancer-induced bone-pain. Sci Rep. 2015 Feb 11;5:8380.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Rabbit Anti ACSL4 Polyclonal Affinity Purified (PBS with 0.05% sodium azide and 50% glycerol, pH7.4)(Western Blot, IHC, ELISA)
Rabbit Anti ACSL4 Polyclonal Affinity Purified (PBS with 0.05% sodium azide and 50% glycerol, pH7.4)(Western Blot, IHC, ELISA)
Lentiviral mouse Slc22a18 shRNA (UAS) - Lentiviral mouse Slc22a18 shRNA (UAS, RFP) (100)
GSTP1 (Glutathione S-transferase P, GST Class-pi, GSTP1-1, FAEES3, GST3) (FITC)